Tag Archives: insulin producing cells

No account yet? Register

Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors

Researchers showed that inhibition of RAC1 activation attenuated pluripotency marker expression and self-renewal ability, while depletion of RAC1b dramatically enhanced stemness features and clonogenic potential.

[Cancers]

[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]

No account yet? Register

Impact of Insulin Producing Cells Derived from Adipose Tissue Mesenchymal Stem Cells on Testicular Dysfunction of Diabetic Rats

Scientists investigated the effect of insulin-producing cells derived from adipose tissue MSCs on diabetic-induced impairments as the abnormalities of testicular tissues, oxidative stress of testes, and defects of spermatogenesis.

[Heliyon]

[zotpress userid=’7992332′ items=’BBBBBBBB’ style=’apa’ cite=’yes’]

No account yet? Register

Review

Pancreatic β-Cell Development and Regeneration

Scientists describe the development and function of β-cells the emerging concept of heterogeneity within insulin-producing cells, and the potential of other cell types to assume β-cell functionality via transdifferentiation.

[Cold Spring Harbor Perspectives in Biology]

[zotpress userid=” items=’ARAWWK77′ style=’apa’ cite=’yes’]

No account yet? Register

New hPSC SOX9 and INS Reporter Cell Lines Facilitate the Observation and Optimization of Differentiation into Insulin-Producing Cells

For the purpose of easy monitoring of differentiation efficiencies into pancreatic progenitors and insulin-producing cells, scientists generated new reporter lines by knocking in a P2A-H-2Kk-F2A-GFP2 reporter gene into the SOX9-locus and a P2A-mCherry reporter gene into the INS-locus mediated by CRISPR/CAS9-technology.

[Stem Cell Reviews and Reports]

[zotpress userid=’7992332′ items=’9KVS8U2E’ style=’apa’ cite=’yes’]

No account yet? Register

Process Parameter Development for the Scaled Generation of Stem Cell-Derived Pancreatic Endocrine Cells

Scientists discuss the potential of both stem cell-derived pancreatic progenitors and more matured insulin-producing cells to treat diabetes.

[Stem Cells Translational Medicine]

[zotpress userid=” items=’IB2BEUUT’ style=’apa’ cite=’yes’]

No account yet? Register

Pancreatic Extracellular Matrix/Alginate Hydrogels Provide a Supportive Microenvironment for Insulin-Producing Cells

Hydrogel prepared with alginate and the pancreatic extracellular matrix was assessed for the beneficial outcomes on encapsulated insulin-producing cells.

[ACS Biomaterials Science & Engineering]

[zotpress userid=” items=’A6V8TGBX’ style=’apa’ cite=’yes’]

Abstract

No account yet? Register

Review

Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type I Diabetes

The design considerations and functional requirements of macroencapsulation systems are reviewed, specifically for stem-cell derived islets, highlighting distinct design parameters.

[Advanced Science]

[zotpress userid=’7753456′ items=’IWQIT6UM’ style=’apa’ cite=’yes’]

No account yet? Register

Tailored Generation of Insulin Producing Cells from Canine Mesenchymal Stem Cells Derived from Bone Marrow and Adipose Tissue

Researchers investigated insulin-producing cell generation from two practical canine MSCs, canine bone marrow-derived MSC, and canine adipose-derived MSCs.

[Scientific Reports]

[zotpress userid=” items=’YLLDGW9P’ style=’apa’ cite=’yes’]

No account yet? Register

Scrt1, a Transcriptional Regulator of β-Cell Proliferation Identified by Differential Chromatin Accessibility during Islet Maturation

Scrt1 expression was controlled by the transcriptional repressor RE-1 silencing transcription factor (REST) and was increased in an in vitro reprogramming system of pancreatic exocrine cells to β-like cells.

[Scientific Reports]

[zotpress userid=’7753456′ items=’TJJIP478′ style=’apa’ cite=’yes’]

No account yet? Register

Full Article Press Release

Glucagon Blockade Restores Functional β-Cell Mass in Type 1 Diabetic Mice and Enhances Function of Human Islets

The authors evaluated the potential for a monoclonal antibody antagonist of the glucagon receptor to maintain glucose homeostasis in type 1 diabetic rodents.

[Proceedings of the National Academy of Sciences of the United States of America]

[zotpress userid=’6807162′ items=’WE3R6XZL’ style=’apa’ cite=’yes’]